Exact Sciences Corporation (EXAS) Rallied on Reporting Strong Results
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
Exact Sciences Corp (EXAS)
Market is closed
News
- First
- << Previous
- 41 - 50
- Next >>
Ark Invest Stock Portfolio: Top 11 Picks
In this article, we discuss the top 11 stock picks of ARK Invest.
Exact Sciences Corporation (NASDAQ:EXAS) Q2 2023 Earnings Call Transcript
Operator: Good day and welcome to the Exact Sciences Second Quarter 2023 Earnings Call. Today's call is being recorded. All lines have been placed on mute to prevent any background noise.
Does Exact Sciences Corporation (EXAS) Have a Long Runway for Growth?
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Best Booming Stocks to Buy Now
DraftKings Inc. (NASDAQ:DKNG) operates a digital sports entertainment and gaming company.
Should You Invest in Exact Sciences Corporation (EXAS) Now?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Exact Sciences Corporation (NASDAQ:EXAS) Q1 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Jordan, and I'll be your conference operator today.
5 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 5 gene editing stocks with the best long-term potential.
Cathie Wood's Stock Portfolio: Top 5 Stock Picks For 2023
On March 15, UiPath Inc. (NYSE:PATH) reported earnings for the fourth quarter of fiscal 2023.
5 Most Promising Gene Editing Stocks According to Analysts
In this article, we will take a look at the 5 most promising gene editing stocks according to analysts.
- First
- << Previous
- 41 - 50
- Next >>
Billionaire Hedge Funds
